Nexalin Technology, Inc.
NXL- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001527352
No open-market purchases or sales by Nexalin Technology, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $281.6K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Nexalin Technology, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +5 vs. Q4 2025
- Shares held
- 1.07M
- +20.6K (+2.0%) vs. Q4 2025
- Total value
- $373.6K
- −$209.8K (−36.0%) vs. Q4 2025
- New holders
- 9
- 3 more added
- Sold out
- 4
- 7 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $281.6K |
| Q1 2026 | 23 | $373.6K |
| Q4 2025 | 19 | $682.6K |
| Q3 2025 | 20 | $638.3K |
| Q2 2025 | 21 | $1.31M |
| Q1 2025 | 17 | $774.5K |
| Q4 2024 | 19 | $1.04M |
| Q3 2024 | 15 | $286.8K |
| Q2 2024 | 13 | $466.9K |
| Q1 2024 | 5 | $88.9K |
| Q4 2023 | 3 | $18.3K |
| Q3 2023 | 5 | $36.0K |
| Q2 2023 | 4 | $11.0K |
| Q1 2023 | 7 | $45.5K |
| Q4 2022 | 7 | $32.5K |
| Q3 2022 | 2 | $21.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Nexalin Technology, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PEAK6 LLC | 384,460 | $133.9K | 0.00% | −92,049−19.3% | Reduced |
| Geode Capital Management, LLC | 247,037 | $86.0K | 0.00% | +96,763+64.4% | Added |
| Vanguard Capital Management LLC | 126,536 | $44.0K | 0.00% | +126,536 | New |
| Vanguard Fiduciary Trust Co | 51,386 | $17.9K | 0.00% | +51,386 | New |
| State Street Corp | 32,300 | $11.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 24,100 | $8.39K | 0.00% | 00.0% | Unchanged |
| Kovack Advisors, Inc. | 23,325 | $8.20K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 23,453 | $8.00K | 0.00% | +23,453 | New |
| StoneX Group Inc. | 22,923 | $7.98K | 0.00% | +22,923 | New |
| UBS Group AG | 22,189 | $7.72K | 0.00% | +6,288+39.5% | Added |
| Susquehanna International Group, LLP | 20,928 | $7.29K | 0.00% | +2,054+10.9% | Added |
| Elevation Advisory Partners LLC | 10,000 | $5.92K | 0.01% | +10,000 | New |
| XTX Topco Ltd | 15,901 | $5.54K | 0.00% | +15,901 | New |
| Raymond James Financial Inc | 12,100 | $4.21K | 0.00% | +12,100 | New |
| Renaissance Technologies LLC | 10,676 | $3.72K | 0.00% | −111,424−91.3% | Reduced |
| Jane Street Group, LLC | 10,510 | $3.66K | 0.00% | −24,506−70.0% | Reduced |
| LPL Financial LLC | 10,447 | $3.64K | 0.00% | −34−0.3% | Reduced |
| Integrated Investment Consultants, LLC | 10,000 | $3.48K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 2,112 | $736 | 0.00% | −226−9.7% | Reduced |
| Advisor Group Holdings, Inc. | 2,100 | $735 | 0.00% | −250−10.6% | Reduced |
| FMR LLC | 1,500 | $522 | 0.00% | −30,125−95.3% | Reduced |
| Farther Finance Advisors, LLC | 1,000 | $355 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,000 | $348 | 0.00% | +1,000 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −39,408−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −30,907−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −28,712−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |